Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Beers

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
The Lancet. Neurology|January 22, 2019
Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapiesDavid R Beers, Stanley H Appel
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 25, 2013
Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosisWeihua Zhao, David R Beers, Stanley H Appel
JAMA Neurology|March 7, 2018
The Role of Regulatory T Lymphocytes in Amyotrophic Lateral SclerosisDavid R Beers, Weihua Zhao, Stanley H Appel
Current Opinion in Neurology|August 17, 2021
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegenerationStanley H Appel, David R Beers, Weihua Zhao
Trends in Immunology|November 3, 2009
T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?Stanley H Appel, David R Beers, Jenny S Henkel
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 9, 2015
Protective and Toxic Neuroinflammation in Amyotrophic Lateral SclerosisKristopher G Hooten, David R Beers, Weihua Zhao, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 5, 2009
Microglia in ALS: the good, the bad, and the restingJenny S Henkel, David R Beers, Weihua Zhao, et al.
Current Neurology and Neuroscience Reports|August 21, 2008
Novel therapeutic targets in neurodegenerative diseases: lessons from amyotrophic lateral sclerosisStanley H Appel, David R Beers, Jenny S Henkel, et al.
Neurology|March 2, 2012
Peripheral nerve inflammation in ALS mice: cause or consequenceOsamu Kano, David R Beers, Jenny S Henkel, et al.
Molecular and Cellular Neurosciences|December 13, 2005
The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALSJenny S Henkel, David R Beers, László Siklós, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
The Lancet. Neurology|January 22, 2019
Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapiesDavid R Beers, Stanley H Appel
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 25, 2013
Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosisWeihua Zhao, David R Beers, Stanley H Appel
JAMA Neurology|March 7, 2018
The Role of Regulatory T Lymphocytes in Amyotrophic Lateral SclerosisDavid R Beers, Weihua Zhao, Stanley H Appel
Current Opinion in Neurology|August 17, 2021
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegenerationStanley H Appel, David R Beers, Weihua Zhao
Trends in Immunology|November 3, 2009
T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?Stanley H Appel, David R Beers, Jenny S Henkel
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 9, 2015
Protective and Toxic Neuroinflammation in Amyotrophic Lateral SclerosisKristopher G Hooten, David R Beers, Weihua Zhao, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 5, 2009
Microglia in ALS: the good, the bad, and the restingJenny S Henkel, David R Beers, Weihua Zhao, et al.
Current Neurology and Neuroscience Reports|August 21, 2008
Novel therapeutic targets in neurodegenerative diseases: lessons from amyotrophic lateral sclerosisStanley H Appel, David R Beers, Jenny S Henkel, et al.
Neurology|March 2, 2012
Peripheral nerve inflammation in ALS mice: cause or consequenceOsamu Kano, David R Beers, Jenny S Henkel, et al.
Molecular and Cellular Neurosciences|December 13, 2005
The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALSJenny S Henkel, David R Beers, László Siklós, et al.
Pageof 5